中医导痰祛瘀药治疗糖尿病合并冠心病临床研究

发布时间：2018-05-06 12:47

  本文选题：糖尿病合并冠心病 + 中医导痰法祛瘀药　； 参考：《亚太传统医药》2017年10期

【摘要】：目的:观察中医导痰祛瘀药治疗糖尿病合并冠心病的临床疗效。方法:将70例糖尿病合并冠心病患者随机分为观察组与对照组35例,对照组患者采用曲美他嗪口服,观察组患者采用中医导痰祛瘀药治疗,观察比较两组患者治疗效果。结果:观察组患者治疗总有效率明显高于对照组(P0.05),且各项检测指标均优于对照组(P0.05)。结论:中医导痰祛瘀药治疗糖尿病合并冠心病效果确切,值得临床推广应用。
[Abstract]:Objective: to observe the clinical effect of traditional Chinese medicine (TCM) for treating diabetes mellitus with coronary heart disease. Methods: seventy patients with diabetes mellitus complicated with coronary heart disease were randomly divided into observation group (n = 35) and control group (n = 35). The patients in the control group were treated with trimetazidine orally, and the patients in the observation group were treated with traditional Chinese medicine to guide phlegm and remove blood stasis. Results: the total effective rate of treatment in the observation group was significantly higher than that in the control group (P 0.05), and all the indexes were better than that in the control group (P 0.05). Conclusion: the effect of traditional Chinese medicine on treating diabetes mellitus with coronary heart disease is definite, and it is worth popularizing.
【作者单位】： 郑州市惠济区人民医院;
【分类号】：R259
，

本文编号：1852374